Position in PCVX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$21,449
+$7 QoQ
Shares Held
369
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#266
of 329 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HUNTINGTON NATIONAL BANK holds $19,857,554 across 103 Biotechnology names. PCVX ranks #31 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27,754 | $13,786,243 | |
| 2 | RPRX |
Royalty Pharma plc
|
55,717 | $3,124,052 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
750 | $467,655 | |
| 4 | INCY |
Incyte Corp
|
3,313 | $375,560 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
701 | $221,579 | |
| 6 | TARS |
Tarsus Pharmaceuticals, Inc.
|
3,446 | $216,891 | |
| 7 | MRNA |
Moderna, Inc.
|
1,596 | $111,767 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
2,815 | $109,813 |
All Filings in PCVX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,449 | 369 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $21,442 | 369 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,025 | 369 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $13,291 | 369 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,941 | 152 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $6,343 | 168 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $12,442 | 152 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $16,797 | 147 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $1,736 | 23 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $341 | 5 | Shares | Defined | 2024-05-03 | |
| 2023-09-30 | $917 | 18 | Shares | Defined | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||